![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Teva Will Cooperate With Opioid Investigations, Oklahoma AG Says
Teva Will Cooperate With Opioid Investigations, Oklahoma AG Says
July 2, 2019
Teva has agreed to cooperate with law enforcement investigations into the opioid crisis under terms of a settlement announced last week.
Oklahoma Attorney General Mike Hunter and Teva agreed last month to settle the state’s claims against the pharma giant for $85 million. Under the final terms of the deal, announced Monday, Teva has agreed that it won’t hire (or contract) with sales reps to sell opioids.
Teva also won’t use speakers’ bureaus and won’t “provide direct or indirect financial support for branded or unbranded information promoting opioids, such as brochures, newsletters, books and guides,” Hunter said.
Upcoming Events
-
21Oct